Zobrazeno 1 - 10
of 1 381
pro vyhledávání: '"Hematologic cancers and related disorders"'
Autor:
Klara Pecankova, Pavla Pecherkova, Zdenka Gasova, Zofie Sovova, Tomas Riedel, Eliézer Jäger, Jaroslav Cermak, Pavel Majek
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
PLoS ONE, Vol 17, Iss 1, p e0262484 (2022)
PLoS ONE
PLoS ONE, Vol 17, Iss 1, p e0262484 (2022)
PLoS ONE
BackgroundExtracellular vesicles are released into body fluids from the majority of, if not all, cell types. Because their secretion and specific cargo (e.g., proteins) varies according to pathology, extracellular vesicles may prove a rich source of
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263195 (2022)
PLoS ONE
PLoS ONE
Background Acute leukaemias (AL) are aggressive but potentially curable blood cancers that can potentially affect women of childbearing age. When a pregnancy is complicated by a diagnosis of AL, clinicians face a complex dilemma: to balance risking t
Autor:
Anshul Agarwal, Aakanksha Khandelwal, Kavita Pal, Naveen Kumar Khare, Vishal Jadhav, Murarilal Gurjar, Sachin Punatar, Anant Gokarn, Avinash Bonda, Lingaraj Nayak, Sadhana Kannan, Vikram Gota, Navin Khattry, Indraneel Mittra
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0262212 (2022)
PLoS ONE
PLoS ONE
Background Transplant related toxicity is a major therapeutic challenge. We have previously reported that the toxicity of chemotherapy is largely not directly because of the drugs themselves; rather it is mainly due to DNA damage, apoptosis and hyper
Autor:
Anna Candoni, Giuseppe Petruzzellis, Alessandra Sperotto, Victoria Andreotti, Marco Giavarra, Carla Corvaja, Alessandro Minisini, Chiara Comuzzi, Carlo Tascini, Renato Fanin, Gianpiero Fasola
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0262784 (2022)
PLoS ONE
PLoS ONE
Introduction Even if now we have available the weapon of vaccination against SARS-CoV-2, the patients with cancer remains a very frail population in which frequently the immunologic response to vaccination may be impaired. In this setting, the SARS-C
Publikováno v:
PLoS Computational Biology
PLoS Computational Biology, Vol 17, Iss 12, p e1009626 (2021)
PLoS Computational Biology, Vol 17, Iss 12, p e1009626 (2021)
Identification of cell phenotypic states within heterogeneous populations, along with elucidation of their switching dynamics, is a central challenge in modern biology. Conventional single-cell analysis methods typically provide only indirect, static
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 12, p e0261250 (2021)
PLoS ONE, Vol 16, Iss 12, p e0261250 (2021)
Many fundamental problems in data mining can be reduced to one or more NP-hard combinatorial optimization problems. Recent advances in novel technologies such as quantum and quantum-inspired hardware promise a substantial speedup for solving these pr
Autor:
Waqas Akram, Muhammad Bilal Ejaz, Syed Azhar Syed Sulaiman, Amer Hayat Khan, Tauqeer Hussain Mallhi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE, Vol 16, Iss 11, p e0259766 (2021)
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE, Vol 16, Iss 11, p e0259766 (2021)
Background Chronic pulmonary aspergillosis (CPA) has a wide spectrum of illnesses depending on the progression of the disease and comorbid conditions. However, there is an inadequacy of investigations regarding clinical, laboratory, risk factor and p
Autor:
Carlos Farkas, Katharina Haigh, Danny Huylebroeck, Nicholas C. Wong, Catherine Carmichael, Thomas Brabletz, Geert Berx, Simone Brabletz, Marc P. Stemmler, Aissa Benyoucef, Christian M. Nefzger, Steven Goossens, Jody J. Haigh, Jose M. Polo, Jueqiong Wang
Publikováno v:
PLoS Biology, Vol 19, Iss 9, p e3001394 (2021)
PLoS Biology, 19(9):e3001394. Public Library of Science
PLoS Biology
PLOS BIOLOGY
PLoS Biology, 19(9):e3001394. Public Library of Science
PLoS Biology
PLOS BIOLOGY
The ZEB2 transcription factor has been demonstrated to play important roles in hematopoiesis and leukemic transformation. ZEB1 is a close family member of ZEB2 but has remained more enigmatic concerning its roles in hematopoiesis. Here, we show using
Autor:
Amrit P. Singh, Frank Schmitz, Adam Z. Rosenthal, Madhav V. Dhodapkar, Antje Hoering, Daisy Alapat, Yan Ren, Maurizio Zangari, Kelsie Smith, Samuel A. Danziger, Jake Gockley, Andrew Dervan, Alexander V. Ratushny, Mark McConnell, Robert M. Hershberg, Suzana Couto, Brian A Walker, Faith E. Davies, Alison Fitch, Wilbert B. Copeland, Gareth J. Morgan, Bart Barlogie, Phil Farmer, David J. Reiss, Brian Fox, Mary H. Young, Frits van Rhee, Cody Ashby, Katie Newhall, Nathan Petty, Michael A Bauer, Robert Z. Orlowski, Matthew Trotter
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 11, p e1003323 (2020)
PLoS Medicine, Vol 17, Iss 11, p e1003323 (2020)
Background The tumor microenvironment (TME) is increasingly appreciated as an important determinant of cancer outcome, including in multiple myeloma (MM). However, most myeloma microenvironment studies have been based on bone marrow (BM) aspirates, w
Autor:
Suárez-García, Inés, Perales-Fraile, Isabel, González-García, Andrés, Muñoz-Blanco, Arturo, Manzano, Luis, Fabregate, Martín, Díez-Manglano, Jesús, Aizpuru, Eva Fonseca, Fernández, Francisco Arnalich, García, Alejandra García, Gómez-Huelgas, Ricardo, Ramos-Rincón, José-Manuel, SEMI-COVID-19 Network
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 8, p e0255524 (2021)
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
PLoS ONE, Vol 16, Iss 8, p e0255524 (2021)
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
BackgroundWhether immunosuppressed (IS) patients have a worse prognosis of COVID-19 compared to non-IS patients is not known. The aim of this study was to evaluate the clinical characteristics and outcome of IS patients hospitalized with COVID-19 com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f059078dfa044e193943863373015cf
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0255524&type=printable
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0255524&type=printable